1741. A Phase 4, Open-label, Multicenter Study to Evaluate the Safety, Tolerability, and Immunogenicity of Vaxelis™ in Healthy Children Previously Vaccinated with a 2-Dose Primary Infant Series of Either Vaxelis™ or Hexyon™ (V419-016)